Cited by 202Nitric Oxide and Endothelin EffectsPhytochemicals and Antioxidant ActivitiesCardiovascular Health and Disease Prevention

The DOI matches its Crossref record; 8 of the 12 references it cites were found in a registry or an index, and 4 are not checked yet; none of the 16 sources its claims cite is checked for support yet.

Improvement of Endothelial Function With Dietary Flavanols Is Associated With Mobilization of Circulating Angiogenic Cells in Patients With Coronary Artery Disease

Open access

Abstract

Objectives In patients with coronary artery disease (CAD) medically managed according to currently accepted guidelines, we tested whether a 1-month dietary intervention with flavanol-containing cocoa leads to an improvement of endothelial dysfunction and whether this is associated with an enhanced number and function of circulating angiogenic cells (CACs).Background Dietary flavanols can improve endothelial dysfunction. The CACs, also termed endothelial progenitor cells, are critical for vascular repair and maintenance of endothelial function.Methods In a randomized, controlled, double-masked, cross-over trial, 16 CAD patients (64+/-3 years of age) received a dietary high-flavanol intervention (HiFI [375 mg]) and a macronutrient- and micronutrient-matched low-flavanol intervention (LoFI [9 mg]) twice daily in random order over 30 days.Results Endothelium-dependent vasomotor function, as measured by flow-mediated vasodilation of the brachial artery, improved by 47% in the HiFI period compared with the LoFI period. After HiFI, the number of CD34+/KDR+-CACs, as measured by flow cytometry, increased 2.2-fold as compared with after LoFI. The CAC functions, as measured by the capacity to survive, differentiate, proliferate, and to migrate were not different between the groups. The HiFI led to a decrease in systolic blood pressure (mean change over LoFI: -4.2+/-2.7 mm Hg), and increase in plasma nitrite level (mean change over LoFI: 74+/-32 nM). Applying a mixed-effects linear regression model, the results demonstrated a significant increase in flow-mediated vasodilation and a decrease in systolic blood pressure with increasing levels of CD34+/KDR+-CACs.Conclusions Sustained improvements in endothelial dysfunction by regular dietary intake of flavanols are associated with mobilization of functional CACs. (Effect of Cocoa Flavanols on Vascular Function in Optimally Treated Coronary Artery Disease Patients: Interaction Between Endothelial Progenitor Cells, Reactivity of Micro- and Macrocirculation; NCT00553774).

Checked 2026-10-06 · 4 references not checked yet

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

In a 30-day randomized crossover trial in 16 medically managed coronary artery disease patients, high-flavanol cocoa improved endothelial function and increased circulating angiogenic cells compared with low-flavanol cocoa. The improvement in flow-mediated dilation and systolic blood pressure tracked with CD34+/KDR+ circulating angiogenic cell mobilization.

Key findings

  • Flow-mediated dilation improved by 47% during the high-flavanol period compared with the low-flavanol period; baseline values were 4.4 ± 0.5% and 4.6 ± 0.5% before the low- and high-flavanol regimens, respectively.
  • CD34+/KDR+ circulating angiogenic cells increased 2.2-fold after high-flavanol intake versus low-flavanol intake, while assays of survival, differentiation, proliferation, and migration did not differ between groups.
  • Systolic blood pressure decreased with high-flavanol intake, reported as a mean change over low-flavanol of −4.2 ± 2.7 mm Hg in the abstract and as a 4.2 ± 0.3 mm Hg decrease in the results; plasma nitrite increased by a mean change over low-flavanol of 74 ± 32 nM.
  • In mixed-effects linear regression, each 1% increase in CD34+/KDR+ circulating angiogenic cells was associated with a 4.6% increase in flow-mediated dilation, a 0.52 decrease in brachial artery diameter, and a 4.44 mm Hg decrease in systolic blood pressure.

Methods

  • Randomized, controlled, double-masked crossover design: 16 CAD patients (64 ± 3 years; 13 male/3 female) completed the study, receiving high-flavanol cocoa (375 mg) or matched low-flavanol cocoa (9 mg) twice daily for 30 days, with a 1-week washout between interventions.
  • Primary and secondary outcomes were brachial artery flow-mediated dilation and circulating angiogenic cell number/function; cells were measured by flow cytometry for CD34/KDR and CD133/KDR and functionally assessed after ex vivo expansion. Tertiary outcomes included plasma nitrite/nitrate, blood pressure, heart rate, and cytokines involved in cell mobilization (VEGF, SDF-1α, SCF).
  • Analysis used two-way repeated-measures ANOVA with Holm-Sidak post hoc tests, plus random-effects linear regression to test associations between CD34+/KDR+ circulating angiogenic cells and outcomes.

Limitations

  • The paper states that the mechanisms underlying the blood pressure effect cannot be determined from this study and that long-term intervention trials are needed; it also notes that small increases after the low-flavanol regimen may reflect non-flavanol bioactives such as methylxanthines or regression to the mean.
  • Evident from the text: the sample was small (16 completers, mostly male), the intervention periods were short (30 days), and no clinical event outcomes were assessed, limiting generalizability and inference about long-term cardiovascular benefit.
  • Evident from the text: the study received an unrestricted research grant from Mars, Inc., a coauthor was employed by Mars, Inc., and the company supplied the cocoa beverage powders, indicating a potential conflict of interest.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2010.03.039

Cites

8 of 12 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 16 cited sources checked · 0 supported · 0 flagged

Show all 19 claims

  • It may state two separate claims as one. 18
  • Probably not a substantial claim. 13
24 of 24
  • The paper relies on this without support.

    The 30-day intervention period is sufficient to produce sustained improvements in endothelial function and circulating angiogenic cell mobilization.

    “Sustained improvements in endothelial dysfunction by regular dietary intake of flavanols are associated with mobilization of functional CACs.”
  • The paper relies on this without support.

    The 16 CAD patients studied are representative of CAD patients medically managed according to current guidelines.

    “The study group consisted of 16 CAD patients having achieved treatment goals in accordance with current AHA/ACC guidelines”
2 of 2

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Conflicting uncertainty for the blood-pressure reduction

    Major

    The abstract and results report the same 4.2 mm Hg reduction relative to LoFI, but give different uncertainties: 2.7 and 0.3 mm Hg. This difference affects how strongly the reported blood-pressure effect is supported.

1 of 1

Citations

Cites

Flagged first, then by citations

Show all 12 references

Cited by

Sorted by citations

Items 201–202 of 202

Metadata

Authors
Heiss, C., Jahn, S., Taylor, M., Real, W. M., Angeli, F. S., Wong, M. L., Amabile, N., Prasad, M., Rassaf, T., Ottaviani, J. I., Mihardja, S., Keen, C. L., Springer, M. L., Boyle, A., Grossman, W., Glantz, S. A., Schroeter, H., & Yeghiazarians, Y.
Affiliations
  • University of California, San Francisco (US)
  • Heinrich Heine University Düsseldorf (DE)
  • University of California, Davis (US)
  • Mars (United States) (US)
Corresponding author
Heiss, Christian
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2010-07
Volume
56
Issue
3
Pages
218-224
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2046356569
Cited by
202
References
12
Citations by year
2026: 4 · 2025: 8 · 2024: 8 · 2023: 13 · 2022: 4 · 2021: 7 · 2020: 6 · 2019: 9 · 2018: 13 · 2017: 9 · 2016: 15 · 2015: 19 · 2014: 10 · 2013: 17 · 2012: 32
FWCI
16.69
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Heart Association
  • Mars, Inc.
  • Mars Inc.
  • N30 Pharmaceuticals
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords
flavan-3-ols, Theobroma cacao, endothelial dysfunction, circulating angiogenic cells, endothelial progenitor cells, coronary artery disease, flow-mediated dilation, CD34+/KDR+ cells, systolic blood pressure, plasma nitrite, dietary intervention, vascular function
MeSH terms
Blood Pressure, Cacao, Coronary Disease, Diet, Double-Blind Method, Endothelium, Vascular, Female, Flavonoids, Humans, Male, Middle Aged, Vasodilation, Neovascularization, Physiologic, Endothelial Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review